+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ulcerative Colitis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4848118
  • Report
  • September 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Avaxia Biologics Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • MORE
The report on the global ulcerative colitis market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global ulcerative colitis market to grow with at healthy CAGR over the forecast period from 2019-2025. The study on ulcerative colitis market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on ulcerative colitis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global ulcerative colitis market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global ulcerative colitis market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • The rising incidence of ulcerative colitis disease across the globe
  • Advancements in healthcare industry
  • Increasing research explorations to develop innovative treatment for ulcerative colitis
2) Restraints
  • Stringent government regulations towards approval of biosimilars
3) Opportunities
  • Unmet needs in the treatment of ulcerative colitis
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global ulcerative colitis market is segmented on the basis of drug type, and disease type.

The Global Ulcerative Colitis Market by Drug Type
  • Anti-Inflammatory Drugs
  • Anti-TNF Biologics
  • Immunosuppressant
  • Calcineurin Inhibitors
  • Other Drug Types
The Global Ulcerative Colitis Market by Disease Type
  • Ulcerative Proctitis
  • Proctosigmoiditis
  • Left-sided Colitis
  • Pancolitis Or Universal Colitis
  • Fulminant Colitis
Company Profiles

The companies covered in the report include
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Johnson & Johnson
  • Sanofi Aventis A/S
  • AstraZeneca plc
  • Abbott Laboratories
  • Merck & Co., Inc.
  • InDex Pharmaceuticals Holding AB
  • Ajinomoto Pharmaceuticals Co., Ltd.
  • Avaxia Biologics Inc.
  • Other companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the ulcerative colitis market.
2. Complete coverage of all the segments in the ulcerative colitis market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global ulcerative colitis market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Avaxia Biologics Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Ulcerative Colitis Market Highlights
2.2. Ulcerative Colitis Market Projection
2.3. Ulcerative Colitis Market Regional Highlights

3. Global Ulcerative Colitis Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Drug Type
3.4.2. Growth Matrix Analysis by Disease Type
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Ulcerative Colitis Market

4. Ulcerative Colitis Market Macro Indicator Analysis

5. Global Ulcerative Colitis Market by Drug Type
5.1. Anti-inflammatory Drugs
5.2. Anti-TNF Biologics
5.3. Immunosuppressant
5.4. Calcineurin Inhibitors
5.5. Other Drug Types

6. Global Ulcerative Colitis Market by Disease Type
6.1. Ulcerative Proctitis
6.2. Proctosigmoiditis
6.3. Left-sided Colitis
6.4. Pancolitis Or Universal Colitis
6.5. Fulminant Colitis

7. Global Ulcerative Colitis Market by Region 2019-2025
7.1. North America
7.1.1. North America Ulcerative Colitis Market by Drug Type
7.1.2. North America Ulcerative Colitis Market by Disease Type
7.1.3. North America Ulcerative Colitis Market by Country
7.2. Europe
7.2.1. Europe Ulcerative Colitis Market by Drug Type
7.2.2. Europe Ulcerative Colitis Market by Disease Type
7.2.3. Europe Ulcerative Colitis Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Ulcerative Colitis Market by Drug Type
7.3.2. Asia-Pacific Ulcerative Colitis Market by Disease Type
7.3.3. Asia-Pacific Ulcerative Colitis Market by Country
7.4. RoW
7.4.1. RoW Ulcerative Colitis Market by Drug Type
7.4.2. RoW Ulcerative Colitis Market by Disease Type
7.4.3. RoW Ulcerative Colitis Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Ulcerative Colitis Market
8.2. Companies Profiled
8.2.1. GlaxoSmithKline plc
8.2.2. Eli Lilly and Company
8.2.3. Johnson & Johnson
8.2.4. Sanofi Aventis A/S
8.2.5. AstraZeneca plc
8.2.6. Abbott Laboratories
8.2.7. Merck & Co., Inc.
8.2.8. InDex Pharmaceuticals Holding AB
8.2.9. Ajinomoto Pharmaceuticals Co., Ltd.
8.2.10. Avaxia Biologics Inc.
8.2.11. Other companies

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • GlaxoSmithKline plc
  • Eli Lilly and Company
  • Johnson & Johnson
  • Sanofi Aventis A/S
  • AstraZeneca plc
  • Abbott Laboratories
  • Merck & Co., Inc.
  • InDex Pharmaceuticals Holding AB
  • Ajinomoto Pharmaceuticals Co., Ltd.
  • Avaxia Biologics Inc.
Note: Product cover images may vary from those shown
Adroll
adroll